QPharma, Inc. Offers On-Demand Printing Services

* Reuters is not responsible for the content in this press release.

Thu Sep 3, 2009 11:36am EDT

MORRISTOWN, N.J.--(Business Wire)--
QPharma, Inc., the industry leader in FDA Regulatory and Compliance Solutions,
announced today the official release of their On-Demand Printing capabilities.
This ordering tool offers QPharma`s pharmaceutical and biotechnology clients a
valuable, cost-saving tool for online printing of variable data materials, such
as sample request forms and disbursements, audit letters, and
representative-triggered mail pieces. 

On-Demand Printing allows sales representatives and management to order only
materials that they need, when they need it, saving time and cost over
traditional printing methods. QPharma`s On-Demand Printing is a proactive
approach to "going green," while eliminating costly overruns and waste of
expired printed materials. 

On-Demand Printing specifically allows QPharma`s clients to generate customized
materials as needed. The variable data printing method produces creative,
personalized marketing pieces that generate customer loyalty and higher response
rates when compared to the traditional generic direct mail approach. 

"This service is especially critical at a time when the industry is cutting back
on the size of sales forces," commented Jeff Volyn, Director of Operations at
QPharma. "Using On-Demand Printing, sales representatives will be able to save
time and cost while maximizing their marketing efforts." 

About QPharma

QPharma is the industry leader in FDA Regulatory and Compliance Solutions. Since
1994, the company has focused on delivering a comprehensive suite of Validation,
PDMA, and Fulfillment Solutions to the FDA-regulated industries. Additional
information can be found at www.qpharmacorp.com. 

For more information on Print-on-Demand, please contact Jessica Labita at 22
South Street, Morristown, NJ 07960, 973-656-0011,
jessica.labita@qpharmacorp.com. 



QPharma, Inc.
Jessica Labita, 973-656-0011
Fax: 973-656-0408
jessica.labita@qpharmacorp.com
www.qpharmacorp.com

Copyright Business Wire 2009

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.